| Trial ID: | L0305 |
| Source ID: | NCT00156949
|
| Associated Drug: |
Epoetin Alfa Dt
|
| Title: |
EPO Deep Tank in Dialysis Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Epoetin alfa DT
|
| Outcome Measures: |
|
| Sponsor/Collaborators: |
Sponsor: Amgen
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
580
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2005-04
|
| Completion Date: |
2007-02
|
| Results First Posted: |
|
| Last Update Posted: |
2010-02-19
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00156949
|
